Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years. (2018)

First Author: Muller I
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/thy.2018.0232

PubMed Identifier: 30351224

Publication URI: http://europepmc.org/abstract/MED/30351224

Type: Journal Article/Review

Volume: 28

Parent Publication: Thyroid : official journal of the American Thyroid Association

Issue: 12

ISSN: 1050-7256